Addressing preventable harm starts with breaking down the data silos that exist within the healthcare landscape and pulling disparate systems together through connected healthcare operations. The post Driving Safer Care for All with Connected Healthcare Operations appeared first on MedCity News ..read more

The FDA has approved Beqvez, a Pfizer gene therapy developed for moderate-to-severe hemophilia B. The one-time treatment carries a $3.5 million price tag, the same as a CSL Behring gene therapy already available for treating the inherited bleeding disorder. The post Pfizer’s First Gene Therapy Approval Sets Up a Showdown With CSL in Hemophilia B appeared first on MedCity News ..read more

This rapidly growing field marries bioinformatics and pharmacology and represents a transformative new era of precision medicine and highly personalized treatments. The post Revolutionizing Primary Care: The Role of Pharmacogenomics and AI in Personalized Medicine appeared first on MedCity News ..read more

Check out news from Alpha Sophia, Handl Health, Alaffia Health, and Summer Health The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News ..read more

Walgreens announced that it is expanding its specialty pharmacy offerings. Experts think that this move could yield several strategic benefits, given the higher profit margins associated with specialty medications compared to traditional drugs. They also think Walgreens’ move could lead to greater competition, consolidation and innovation within the broader pharmacy industry. The post How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry? appeared first on MedCity News ..read more

If you advise self-insured employers on healthcare benefits, your expert insights will help provide a comprehensive perspective of the state of healthcare benefits for employers in our second annual survey, the 2024 Benefit Consultant Sentiment THE INDEX. The post Which AI Applications Interest Your Employer Clients the Most? Where Will They Have the Greatest Impact? appeared first on MedCity News ..read more

Embedding patient financing options into the billing process presents a very clear solution for providers and patients to balance affordability and increase collectability. The post Debunking the Myths Around Patient Financing appeared first on MedCity News ..read more

How health tech startups can successfully adapt the principles to their business ideas The post Examining the Usefulness of the Lean Startup Method in Building Health Tech Products appeared first on MedCity News ..read more

More than 33,000 Providence employees filed a class-action complaint against the health system in 2021, alleging that it had been withholding their wages by denying them breaks and rounding down their working hours. Last week, Providence was ordered to pay more than $200 million in damages — a decision that “sends a message to healthcare corporations,” according to an attorney representing the workers. The post Providence Ordered to Pay $200M for ‘Systemic Wage Violations’ appeared first on MedCity News ..read more

Day One Biopharmaceuticals drug Ojemda is now FDA-approved for advanced pediatric low-grade glioma, the most common type of brain cancer in children. The regulatory decision for Ojemda covers a broader swath of patients than a drug combination from Novartis approved for treating this childhood cancer. The post FDA Drug Approval Marks a New Day for Treating Pediatric Brain Cancer appeared first on MedCity News ..read more